Caron’s Wally CO2 incubators for laboratories are now available for purchase in the European Union.

The final part of the European Falsified Medicines Directive (EU FMD) is to come into force on Feb. 9, 2019, which means that all medicines within the European Union will need to comply with the safety features as laid out by the delegated regulation.

Nine award winners from the 2019 edition of Pharmapack Europe, covering innovations across drug delivery, packaging, and materials and components, have been announced by the event organizers.

The company will expand its global R&D footprint at its facility in Billerica, MA, with a $70-million investment.

The companies will jointly develop and commercialize an investigational bifunctional fusion protein immunotherapy currently in clinical development for cancer treatment.

PDA survey and conference discussion will generate information to guidance on technology transfer.

Mixing Dynamics has been selected as North American representative for Italvacuum dryers and pumps.

Supply chain players are eligible to participate in FDA’s pilot program to develop an electronic system for tracking drug products.

The companies will develop a software-connected pipetting system for improved reproducibility and traceability in life-science laboratories.

Researchers used magnesium particles as tiny motors to deliver an oral vaccine against the bacterial pathogen Staphylococcus aureus.

A study funded by the National Institutes of Health has created a virtual library expected to expand the availability of “make-on-demand” molecules for drug discovery.

Honeywell introduces Aclar Accel barrier film with faster production and delivery for pharma packaging.

The agency is requiring companies that make sartan blood pressure drugs to review their manufacturing processes due to the problem with impurities.

PCI Pharma Services expanded capacity of its commercial packaging site in Illinois.

The agency recommended six medicines for approval at its January 2019 meeting, including treatments for lung cancer, HIV-1, and autoimmune disorders.

The companies will develop Amprologix’s lead epidermicin-based antibiotic candidate.

The company will open its first European manufacturing facility in Castlebar, Ireland.

The US Pharmacopeial Convention’s new plan will include new and revised quality standards and activities to support the development of new generic drugs.

In a deal potentially worth up to $460 million, Genentech and Xencor will develop and commercialize novel cytokine therapeutics.

A solid lipid excipient from ABITEC is designed for multiple dosing forms.

A new reactor flask heating system now offered by Asynt allows the conduction of safe experiments in academic teaching and research labs.

Keeping abreast of the latest industry trends and retaining flexibility are key to maintaining a strong market position.

New HHS proposal would remove the current safe harbor protection from the federal Anti-Kickback Statute for rebates or discounts provided to Medicare Part D drug plans and certain state Medicaid programs.

Company launches new services dedicated to emerging biotech and biopharma companies.

As we approach the next instalment of Pharmapack Europe, a potentially perilous situation in relation to drug packaging has emerged for pharmaceutical companies should Brexit result in a ‘no deal’ scenario.

Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.

Political instability is causing uncertainty in Europe and wreaking havoc with US regulatory timeframes.

Various groups and stakeholders from pharma, healthcare, and government are responding to a new draft environmental risk assessment guidance from EMA.